Incidence of Benign and Malignant Neoplasms in Crohnʼs Disease Patients Aged ≤30 Years Versus 30-64 Years Treated With Certolizumab Pegol: Results From a Pooled Safety Analysis of 15 Studies

Autor:	Christina Ha, Jason Coarse, Gordana Kosutic, Iram Hasan, Marshall Spearman, Edward V. Loftus, Jennifer M. Choi
Rok vydání:	2015
Předmět:	medicine.medical_specialty Hepatology business.industry Internal medicine Incidence (epidemiology) Gastroenterology medicine Disease Certolizumab pegol business medicine.drug
Zdroj:	American Journal of Gastroenterology. 110:S778
ISSN:	0002-9270
DOI:	10.14309/00000434-201510001-01831
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::461e913bba944a6bd7b98f9118a7105d https://doi.org/10.14309/00000434-201510001-01831 Zobrazit plný text záznamu